Mutations of TMEM165 are linked to a subtype of inborn metabolic diseases affecting the glycosylation pathway, and TMEM165 is a functional homolog of the Golgi-localized ScGdt1 [7]. This evidence concerns the gene TMEM165 and Other metabolic disease.